A pilot program that arranges delivery of healthy food to heart failure patients after hospital discharge shows promise for ...

Southlake, Texas – November 10, 2025 – PRESSADVANTAGE – Mills Wealth Advisors, LLC announced a live, no-cost online masterclass on Friday, November 14, 2025, at 11 AM CST / 10 AM MST, focused on the ...

Explore FPA Crescent Fund's Q3 2025 performance, which gained 5.54%. Get key insights on top contributors like Alphabet and ...

Appointed key leadership to drive (Z)-endoxifen development and evolve pathway to commercialization SEATTLE, /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a ...

This high-intensity session is designed for maximum effort, maximum effect—all in minimal time. But it's not easy.

President Donald Trump has signed a government funding bill to end a record 43-day shutdown that caused financial stress for ...

The program will rely on the technology to help decide if procedures are eligible for coverage, which Sen. Murray called a ...

The Canadian art CEO who left a top post at the National Gallery of Canada to lead the Philadelphia Art Museum is now suing the U.S. institution over her dismissal.

Diversified Royalty Corp. (TSX: DIV and DIV.DB.A) (the “Corporation” or “DIV”) is pleased to announce its financial results for three months ended September 30, 2025 (“Q3 2025”) and nine months ended ...

SBM Offshore has scheduled a conference call, which will be followed by a Q&A session, to discuss the Third Quarter 2025 Trading Update. The event is scheduled for Thursday November 13, 2025, at 10.00 ...

The FDA has cleared a phase 3 trial for lacutamab in CTCL, following promising phase 2 results showing durable activity and safety. TELLOMAK 3 will assess progression-free survival with two cohorts: ...